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Background: In Ethiopia, light microscopy is the gold standard for malaria diagnosis although it is not available in
most peripheral health facilities. It is time consuming, requires trained personnel and needs careful preparation and
application of reagents to ensure quality results. This study was aimed at testing the diagnostic performance of
CareStart™ malaria rapid diagnostic test (RDT) with reference to light microscopy for the diagnosis of falciparum
and vivax malaria in Ethiopia.
Methods: Blood samples were collected from 254 patients suspected to have malaria at Kola Diba Health Center in
the late malaria transmission peak season from November 2011 to December 2011. The samples were examined
immediately by light microscopy and the RDT (CareStart™ Malaria HRP2/pLDH COMBO Test kit). Statistical analysis
was performed using SPSS version 16 and the JavaStat two-way contingency table analysis.
Results: The overall sensitivity and specificity of CareStartTM RDT was found to be 95% (90–97.9%, 95% CI) and
94.2% (90.9–96%, 95% CI), respectively. The sensitivity of the CareStartTM RDT for Plasmodium falciparum or mixed
infection was calculated to be 92.9% (82.5–98%, 95%CI) while a sensitivity of 90.9% (74.1–98.4%, 95%CI) was found
for non-falciparum species. The specificity for P. falciparum or mixed infections was found to be 95.4% (92.5–96.8%,
95%CI) while it was 97.3% (94.8–98.4%, 95%CI) for non-falciparum species. There was an excellent agreement
between the two tests with a kappa value of 0.918.
Conclusion: The CareStartTM RDT test showed good sensitivity and specificity with an excellent agreement to the
reference light microscopy. The RDT could therefore be used in place of light microscopy, which in poor set-ups
cannot be used routinely.
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Malaria is ranked as the leading communicable disease
in Ethiopia, accounting for about 30% of the overall Dis-
ability Adjusted Life Years lost. Approximately 68% of
the total population of 78 million lives in areas at risk
of malaria [1]. According to Ethiopia’s Federal Ministry
of Health (FMOH), in 2008/2009, malaria was the lead-
ing cause of outpatient visits, health facility admissions* Correspondence: beyemoges@gmail.com
1Department of Immunology and Molecular Biology, School of Biomedical
and Laboratory Sciences, College of Medicine and Health Sciences, University
of Gondar, 196, Gondar, Ethiopia
Full list of author information is available at the end of the article
© 2012 Moges et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orand inpatient deaths, accounting for 12% of reported
outpatient visits and nearly 10% of admissions. Because
a large proportion of the population does not have
access to health care services, these figures probably
under-estimate the true burden of malaria in the country
[1]. In Ethiopia, Plasmodium falciparum and Plasmo-
dium vivax are the major parasites accounting for about
70% and 30% of infections, respectively, during peak
transmission periods [2,3].
The malaria transmission pattern in Ethiopia is highly
seasonal and unstable [4]. Because of this unstable trans-
mission and infrequent exposure to infection, immunity
is generally under-developed and all age groups are atLtd. This is an Open Access article distributed under the terms of the Creative
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children under five years of age are the most vulnerable
groups, the population at age five and older is also high
risk [4].
In the prevention and control of malaria, prompt and
accurate diagnosis is the key to effective disease man-
agement [5]. However, in Ethiopia, clinical diagnosis
and empirical treatment has been the mainstay of mal-
aria management in areas where laboratory facilities are
not available. Due to the non-specific nature of signs
and symptoms of malaria, clinical diagnosis is unreliable
[3,5,6]. In many countries malaria is still being diag-
nosed clinically, an unreliable method leading to over-
diagnosis and over-treatment [7]. Light microscopy
(LM) remains preferred and standard for laboratory
diagnosis of malaria although it is not accessible and af-
fordable in most peripheral health facilities in the coun-
try. Moreover, microscopy is time consuming, requires
trained personnel and needs careful preparation and ap-
plication of reagents to ensure quality results [6,8]. For
a better and sustainable control, malaria diagnosis
requires a more rapid, easy, sensitive and specific
method.
Malaria rapid diagnostic test (RDT) was introduced in
the 1990s and has undergone many improvements [9].
The CareStart™ Malaria HRP-2/ pLDH (Pf/PAN) Combo
Test is a three-band RDT detecting HRP-2 and PAN-
pLDH. RDTs for detection of P. falciparum and other
species have been used by health extension workers
(HEWs) at health posts in Ethiopia since 2005 [10-14]. It
is a new tool for the rapid qualitative determination of
malaria histidine-rich protein 2 (HRP2) and lactate de-
hydrogenase in human blood, aiding the diagnosis of
malaria infection.
This study was conducted to evaluate the sensitivity
and specificity of CareStart™ rapid malaria test in refer-
ence to the conventional LM in north-west Ethiopia.
Methods
Study area and period
The cross-sectional study was conducted at Kola Diba
Health Center in Dembia District from November to
December 2011, which was a peak transmission season
in Ethiopia. The district is malarious and covers an area
of 1,270 km2. The altitude of the district ranges between
1,750 and 2,100 m above sea level. It has a population of
more than 300,000 and the majority of its population
depends on subsistence farming. Kola Diba Health Cen-
ter is one of the health centres in the district where
people with symptoms suggestive of malaria obtain free
services for diagnosis and treatment. Despite the pres-
ence of different control activities in the area, it
remained endemic for both P. vivax and P. falciparum
malaria despite a strong control effort.Study subjects
Two hundred and fifty four malaria suspected patients
attending the medical and paediatric out-patient depart-
ments of Kola Diba Health Center during the study
period were included and screened for malaria infection
using LM and the CareStart™ RDT. Patients who had
received anti-malarial drugs during the past four weeks
and critically ill patients who were unable to give blood
were excluded from the study.Specimen collection and processing
The socio-demographic characteristics and clinical data
of the participants were collected using a structured
and pre-tested questionnaire. Finger-prick samples were
collected and placed in a grease-free, clean, glass slide.
The same finger-prick blood sample was used to carry
out the RDT in parallel, following manufacturer’s
instructions. In a single slide, both thick and thin films
were prepared. The thin films were fixed in methanol
after air-drying, the slides were stained in 10% Giemsa
solution for 15 min. Thin and thick films were read at
the health centre by an experienced laboratory techni-
cian and the result was considered negative if no para-
sites were seen after examination of 200 fields at
1,000x magnification. The technician was blinded to
the results of the RDT. All blood films were re-read a
second time by an experienced microscopist at Gondar
University Hospital laboratory who was also blinded to
initial microscopy and RDT results. In cases where the
results were discordant, a third expert reader was used.
The results of the third expert reader were considered
final. All the microscopists were from Gondar Univer-
sity Hospital laboratory. The laboratory is labelled as
three star laboratory during the national pre-
accreditation assessment by the Ethiopian Health and
Nutrition Research Institute (EHNRI) which is on the
final stages of accreditation by the WHO-AFRO. The
laboratory is involved in external quality assurance
(EQA) at EHNRI and the Amhara Regional Research
and Diagnostic Laboratory. All the microscopists
involved in the study had pre-study training and were
qualified.Statistical analysis
The collected data were computerized using Excel pro-
gram, exported and analysed by SPSS version 16 and
JavaStat two-way contingency table analysis. Sensitivity,
specificity, and positive and negative predictive values
were determined for both tests and compared with one
another. Kappa value was determined to see the
consistency of the results among the diagnostic tools. A
P value of less than 0.05 was considered significant in all
comparisons.
Table 2 Parasite positivity detected by light microscopy
based on patient signs and symptoms using logistic
regression analysis
Symptoms Light microscopy
P N OR 95%CI
Fever 103 149 1.447 0.89-23.39
Headache 97 131 0.498 0.201-1.231
Fatigue 89 111 0.48 0.249-0.926
Sweating/chills/rigours 87 114 0.619 0.326-1.174
Vomiting 54 73 0.878 0.532-1.448
Splenomegaly 17 11 0.405 0.181-0.905
Myalgia and arthralgia 18 24 0.910 0.466-1.778
Anaemia 5 6 0.825 0.245-2.778
Hypoglycaemia 6 7 0.8 0.261-2.451
CI=confidence interval; LM=light microscopy; N=negative; OR=odds ratio;
P=positive.
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Ethical clearance was obtained from the Institutional Re-
view Board (IRB) of the University of Gondar, College of
Medicine and Health Sciences. Verbal consent was taken
from all study participants and mothers/guardians of all
children under 18 after explaining the purpose and ob-
jective of the study. Participants who were diagnosed to
have malaria were given the appropriate treatment at the
health centre.
Results
A total of 254 malaria-suspected patients were included
in the study. The male to female ratio was 1.57:1 while
the mean age (SD, range) of the participants was 21.4
years (14.76, 0.4–75). Most of the participants were from
rural areas of the district (77.2%). Table 1 describes para-
site positivity as detected by LM among different socio-
demographic factors of patients. Using logistic regression
analysis the sex (OR=0.551, 95%CI=0.325–0.932) and
resident of the participants (OR=0.483, 95%CI=0.254–
0.919) were found to be significantly associated with
parasite positivity. Table 2 describes the presenting symp-
toms of patients and the rate of parasite positivity. Fever
was the most commonly reported presenting symptom
by the participants (99.2%) while headache (89.8%),
sweating/chills/rigors (79.1%), fatigue (78.7%), and vomit-
ing (50%) were other common presenting features. OnlyTable 1 Parasite positivity as detected by light microscopy am
using logistic regression analysis
Patient variables Parasite positivity by the LM
No. tested% N
Sex Male 155(61) 7
Female 99(39) 3






Residence Rural 197(77.2) 8
Urban 57(22.4) 1
Educational status Illiterate 155(61) 5
Primary school 47(18.5) 2
Secondary school 43(17) 1
College 9(3.5) 3




CI=confidence interval; LM=light microscopy; OR=odds ratio.40.9% (95%CI, 40.2–41.7%) of the febrile patients were
diagnosed to have malaria. Using the logistic regression
analysis it is only fatigue (OR=0.48, 95%CI=0.249–0.926)
and splenomegally (OR=0.405, 95%CI=0.181–0.905)
associated with malaria positivity using the LM.
The overall parasite positivity using LM was 104
(40.9%): 40 (15.7%) for P. falciparum, 58 (22.8%) for
P. vivax and six (2.4%) for mixed infections. Using
the CareStartTM RDT, the overall parasite positivity wasong different socio-demographic factors of patients
o. positive% No. negative% OR 95%CI
2(46.5) 83(53.5) 0.551 0.325-0.932
2(32.3) 67(67.7)
2(27.3) 32(72.6) 1.939 0.629-5.984
7(58.7) 19(41.3) 0.512 0.173-1.512
5(41.7) 49(59.3) 1.018 0.371-2.792
6(36.4) 28(63.6) 1.273 0.424-3.818
(35.3) 11(64.7) 1.333 0.346-5.136
(42.1) 11(64.7)
8(44.9) 109(55.3) 0.483 0.254-0.919
6(28.1) 41(71.9)
9(38.1) 96(61.9) 0.814 0.196-3.377
9(61.7) 18(38.3) 0.31 0.069-1.399
3(30.2) 30(69.8) 1.154 0.25-5.335
(33.3) 6(66.7)
1(42.5) 42(57.5) 1.185 0.389-3.617
1(43.5) 80(56.7)
(20) 20(80) 1.148 0.395-3.338
(46.7) 8(53.3) 3.50 0.854-14.342
Table 3 Malaria parasite positivity based on light microscopy and CareStartTM RDT
LM CareStartTM RDT









P.falciparum 18 (7.1) 2 (0.8) 15 (5.9) 5 (1.9) 40 (15.7) <0.001
P. vivax 28 (11) 20(7.9) 6(2.4) 4(1.6) 58(22.8)
Mixed 1(0.4) 0 (0) 5(1.9) 0(0) 6(2.4)
Negative 3(1.2) 2(0.8) 0(0) 145(57.1) 150(59.1)
Total 50 (19.7) 24 (9.4) 26(10.2) 154(60.6) 254(100)
LM=light microscopy; Pf=Plasmodium falciparum; RDT=rapid diagnostic test.
* Chi square test was used to calculate the p value.
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P. vivax and 26 (10.2%) for mixed infections (Tables 3).
Difference in detection of malaria parasites using either
the LM or the RDT was insignificant (P<0.001). The dif-
ference of in detection of P. falciparum parasite using ei-
ther tests was also insignificant (P<0.001). However,
difference in detection of P. vivax using the LM and
RDT was found to be significant (P<0.001). Considering
mixed infection as P. falciparum, the difference of detec-
tion was found to be significant (P<0.001).
Taking the LM as a standard test for malaria, the sen-
sitivity and specificity of CareStartTM RDT was found to
be 95% (90–97.9%, 95% CI) and 94.2% (90.9–96%, 95%
CI), respectively. The positive predictive value (PPV)
and the negative predictive value (NPV) were found to
be 91.3% (86.5–94.1%, 95% CI) and 96.7% (93.3–98.6%,
95% CI), respectively. There was an excellent agreement
between the LM and CareStartTM RDT with a Kappa
value of 0.918 (0.852–0.955, 95% CI) (Table 4).
Since both the Pf-specific and the ‘PAN’ antigen used
by the CareStartTM RDT are detected in P. falciparum
infections, giving the result “Pf plus PAN” even for non-
mixed P. falciparum infections, it was not possible to
directly compare the performance of the test against P.
falciparum single infections detected by LM. Therefore,
the sensitivity and specificity of “Pf or mixed” (by LM)
to “Pf plus PAN” (by RDT) were compared, whilst non-
falciparum infections detected by LM were compared
directly to the “PAN only” RDT results (Table 4). Ac-
cordingly, the sensitivity of the CareStartTM RDT for P.






Pf or mixed by LM vs pf/pan by RDT 92.9 (82.5-98) 95.4 (92.5-9
Non-Pf (by LM) vs Pan only (by RDT) 90.9 (74.1-98.4) 97.3 (94.8-9
All positive by LM vs all positive by RDT 95 (90–97.9) 94.2 (90.9-9
Pf=Plasmodium falciparum; LM=light microscopy; RDT=rapid diagnostic test; PPV=p
*P<0.001.calculated to be 92.9% (82.5–98%, 95%CI) while a sensi-
tivity of 90.9% (74.1–98.4%, 95%CI) was found for non-
falciparum species. The specificity for P. falciparum or
mixed infections was found to be 95.4% (92.5–96.8%,
95%CI) while it was 97.3% (94.8–98.4%, 95%CI) for non-
falciparum species (Table 4).
Of note in the present study was an excellent agree-
ment between CareStartTM RDT and LM with a Kappa
value of 0.918. There was also a very good agreement
between the RDT and LM in detecting different species
of Plasmodium: Kappa value of 0.853 for P. falciparum
or mixed infection and Kappa value of 0.849 for non-
falciparum species.
Discussion
The present study revealed a high sensitivity and specifi-
city of the CareStartTM RDT (Table 4). The high sensi-
tivity of the RDT in this study was in line with other
studies from south-west Ethiopia [11] and Madagascar
[15]. The current study revealed a higher sensitivity and
a slightly lower specificity than reports from Myanmar
[16]. Overall, the CareStartTM RDT showed good sensi-
tivity when compared to the LM. In set ups where health
personnel rely on their clinical judgment, using RDT for
the diagnosis of malaria can be helpful for early institu-
tion of treatment.
This study had also tried to evaluate the performance
of the CareStartTM RDT in detecting different species of
malaria parasite. The finding in the current study was
higher than that reported by Ashton et al from Oromia






tests Kappa (95% CI)
6.8) 84.8(75.3-89.5) 98 (95–99.4) 0.853(0.726-0.916)
8.4) 83.3 (67.9-90.1) 98.6 (96.1-99.7) 0.849(0.663-0.931)
6) 91.3( 86.5-94.1) 96.7(93.3-98.6) 0.885(0.803-0.933)
ositive predictive value; NPV=negative predictive value.
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fection was also higher than that by Maltha et al (78.5%)
[18]. However, the sensitivity in this study was found to
be lower than reports from south-west Ethiopia [11],
south Ethiopia [12] and Madagascar [15]. These differ-
ences could be due to observer variation, difference with
malaria species circulating at different localities or host
factors [19].
The specificity of the CareStartTM in the present study
for P. falciparum or mixed infections was higher than
the reports from Oromia Regional State in Ethiopia and
Madagascar [15,17] and lower than the reports from
southern [12] and south-west Ethiopia [11]. The specifi-
city for the non-falciparum species in the current study
was comparable to the reports of some studies [17],
higher in some others [15] and lower in elsewhere
[11,12]. The differences in the specificity of the RDT
could be due to the aforementioned reasons [19].
The RDT had high NPV, meaning that it was reliable
in ruling out malaria. Similarly, the higher PPV means
that patients will be correctly diagnosed as positive for
malaria and avoids unnecessary treatment.
The overall prevalence of malaria in the study area
was very high, as detected by either the CareStartTM
RDT (39.4%) or the LM (40.9%). The result was higher
than the report from Oromia Regional State in Ethiopia
(23.2%) [17] while it was in agreement with a report
from three regions in Ethiopia [20]. The high prevalence
could be partly explained by the fact that the study was
conducted in a peak malaria transmission season in the
country. Also, the malaria transmission pattern in Ethi-
opia is highly seasonal and unstable. Because of this un-
stable transmission and infrequent exposure to infection,
immunity is generally under-developed and all age
groups are at risk of malarial disease [19]. On the other
hand, it might be due to development of anti-malarial or
insecticide resistance in the area [5]. The knowledge, at-
titude and practice of the participants could also be a
factor [19]. However, these assumptions should be evalu-
ated with further studies. The high prevalence of mal-
aria, despite the tremendous effort to distribute bed nets
and apply outdoor insecticides, heralds the need to
evaluate the malaria control system in the area and
beyond.
Current subjective or objective fever (axillary
temperature of >37.50c) was the most common present-
ing symptom by the participants (Table 2). Fever detects
only 40.9% malaria. This could be explained by the fact
that individuals may carry parasites without symptoms.
On the other hand, the significant overlap of malaria
symptoms with other tropical diseases might have
impaired the specificity of fever and encouraged the in-
discriminate use of anti-malarials for managing febrile
conditions in endemic areas. Studies of fever cases inPhilippines, Sri Lanka, Thailand, Mali, Chad, Tanzania
and Kenya have shown high percentages of malaria over-
diagnosis when using fever as a clinical diagnostic tool
[21-27]. Comprehensive investigation to identify the
etiologic agents of febrile illnesses could be helpful in
the study area and beyond. Defining the malaria-
attributable fraction to estimate the frequency of true fe-
brile malaria among all febrile cases, by fitting the risk of
fever as a function of parasite density using a logistic re-
gression model, would be of paramount importance
[28].
Conclusion
The CareStartTM RDT test showed good sensitivity and
specificity with an excellent agreement to the reference
LM. The RDT could therefore be used in place of LM,
which in poor set-ups cannot be used routinely.
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